ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,159, issued on July 29, was assigned to Metabolic Technologies LLC (Missoula, Mont.).

"Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics" was invented by Jay Hoffman (Oviedo, Fla.) and John Rathmacher (Story City, Iowa).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a composition comprising HMB and at least one probiotic. Methods of administering HMB and at least one probiotic to an animal are also described. HMB and probiotics are administered to attenuate inflammatory cytokine markers and/or maintain muscle integrity."

The patent was filed on May 18, 2020, under Application No. ...